Ƭhe deal, ωhich was announced in February, is thȩ largest imagine a Nσrth Americαn coȵtroller ⱨas eⱱer made on the largest medicαl cannabis market įn Europe and reflects a generally optimistic outlook on the Western market.
Although it may be the most important deal ever announced, especially from a Western perspective, it is not by itself the only significant M&, A offer to have been.
European cannabis grower MG Health Limited and German cannabis grower MG Health Limited announced merger ideas only this year. Just days after Tilray announced its$ 40 million consolidation of Brewdog, Canify made the announcement.
These cases only serve to illustrate the ice. More than a few additional major M&, A talks have been announced worldwide since September 2025.
Company knowledge
A Tracker and Cannabis M&
A regularly updated database that records big mergers, acquisitions, and offers that have impacted the world cannabis market since 2020.
Cannabis-related company brains
Explore sensor
- Financials for InterCure / ISHI ( Botanico Ltd. ) on September 19, 2025 are undisclosed.
- High Tide/Remexian Pharma ( includes$ 53 million total equity value ): September 2025
- Vireo and Schwazze will acquire the majority of Schwazze’s 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico for$ 62 million in notes with a$ 91 million face value ( 30 % discount at par ).
- Cronos / CanAdelaar US$ 67 million forthright plus EBITDA-based earnout on December 9, 2025
- Canopy Growth / MTL Cannabis C$ 179 million business value as of December 15, 2025.
- $ 47 million in base consideration ( 84 million subordinate voting shares at$ 0. 56 per share ) is received on December 22, 2025, from Vireo/Eaze.
- Vireo/PharmaCann Colorado’s$ 49 million all-stock property plus the notion of some liabilities as of December 16, 2025
- December 30, 2025 – TerrAscend / Union Chill full determination of$ 13 million
- Wyld / Grön Financials unknown on January 5, 2026.
- January 06, 2026 – Nabis / Humble Cannabis Solutions ~$ 33m
- Reverse takeover of Little Green Pharma and Cannatrek ( all stock transaction ) on January 14, 2026.
- February 5, 2026– Cannabist Virginia possessions$ 130 million loan-to-own – Millstreet Credit Fund
- February 18, 2026 – Organigram / Sanity Group up to €250m ( €113. 4m upfront, earnout of up to €113. 8m )
- Verdant Capital Partners / Native Roots 17 Colorado shops, March 3, 2026, financial information unknown
- Tilray / BrewDog pay$ 33 million for the UK’s 11 breweries and international brands, UK making functions, and BrewDog’s international brand and Internet on March 2, 2026.
- Canify AG/MG Health Financials unidentified on March 12, 2026.
With this in mind, it seems unlikely that we are yet to experience the long-awaited “tidal storm” of marijuana M&, A offers.
However, with thousands of businesses working in a fragmented global hemp business,” some M&, A is occurring,” according to Mitchell Osak, a planner, expert, and author of the Cannabis Management Review.
According to him,” a lot of big, strategic deals that meaningfully impact sector revenue, market buildings, and the student business effectiveness” must take place for this to represent a real wave. “
Osak asserts in a prolonged study that was made public earlier this year and was seen by Business of Cannabis that neither the sector’s financial or structural health level was currently high enough to raise that table. The macro setting is too vulnerable for something resembling a coastal wave in 2026, Schedule III is also commonly misunderstood, and balance sheets are also stretched.
Not everyone, however, agrees with that assessment. Seth Yakatan, α cannabis investσr, claims thαt the sector may already be in the eaɾly sƫages of a consolidation cyclȩ. He argues that it’s wrong to anticipate the upcoming wave of cannabis M&, A mergers to resemble the headline-driven mergers that have characterized other sectors.
To read Mitchell Osak’s arguments in detail, go to page 2.
